Psychemedics Corporation
PMD was delisted on the 12th of December, 2024.
21 hedge funds and large institutions have $6.64M invested in Psychemedics Corporation in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 2 closing their positions.
9% less funds holding
Funds holding: 23 → 21 (-2)
30% less capital invested
Capital invested by funds: $9.54M → $6.64M (-$2.9M)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WS
Wedbush Securities
Los Angeles,
California
|
+$65.7K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$9.26K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.79K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$578 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$59 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$149K |
| 2 |
Renaissance Technologies
New York
|
-$92.6K |
| 3 |
CC
Cannell Capital
Alta,
Wyoming
|
-$85K |
| 4 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$57.9K |
| 5 |
CIC
Crawford Investment Counsel
Atlanta,
Georgia
|
-$56.4K |
PMD Hedge Fund Activity: Q4 2022 in Review
21 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q4 2022, worth a combined $6.64M — down 30% from $9.54M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PMD and 1 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 5 added.
The largest buyer was Wedbush Securities, adding an estimated $65.7K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $149K sold.
- 21 institutional investors held Psychemedics Corporation (PMD) as of Q4 2022, down from 23 in Q3 2022.
- Funds reported $6.64M of Psychemedics Corporation stock for Q4 2022, down 30% quarter-over-quarter.
- 1 fund opened new Psychemedics Corporation positions in Q4 2022 and 2 closed out, a net change of -1 holder.
- The largest Psychemedics Corporation buyer in Q4 2022 was Wedbush Securities, an estimated $65.7K added.
- The largest Psychemedics Corporation seller in Q4 2022 was Susquehanna International Group, an estimated $149K sold.
Based on aggregated 13F filings for Q4 2022.